BMB-101

DRUG3 trials

Sponsors

Bright Minds Biosciences Pty Ltd

Conditions

Absence EpilepsyDravet SyndromeHealthyJeavons SyndromeLennox Gastaut SyndromePrader-Willi Syndrome

Phase 1

A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers

CompletedNCT05397041

Bright Minds Biosciences Pty LtdHealthy

Start: 2022-06-06End: 2023-05-04Updated: 2023-07-06

Phase 2

BMB-101 in Absence Epilepsy and DEE

RecruitingNCT06401538

Bright Minds Biosciences Pty LtdAbsence Epilepsy, Dravet Syndrome, Jeavons Syndrome +1

Start: 2024-12-05End: 2025-11-30Target: 20Updated: 2025-08-12

A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.

Not yet recruitingNCT07266324

Bright Minds Biosciences Pty LtdPrader-Willi Syndrome

Start: 2026-01-31End: 2027-03-31Target: 16Updated: 2025-12-05